Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 HKD | +5.88% | +4.65% | +25.00% |
27/03 | Uni-Bio Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
14/02 | Uni-Bio Science's Profit to Climb in 2023 | MT |
Sales 2022 | 440M 56.35M 4.7B | Sales 2023 | 485M 62.03M 5.17B | Capitalization | 452M 57.85M 4.83B |
---|---|---|---|---|---|
Net income 2022 | 38M 4.86M 406M | Net income 2023 | 70M 8.96M 747M | EV / Sales 2022 | 0.85 x |
Net cash position 2022 | 85.82M 10.98M 916M | Net cash position 2023 | 85.56M 10.95M 913M | EV / Sales 2023 | 0.76 x |
P/E ratio 2022 |
11.9
x | P/E ratio 2023 |
6.49
x | Employees | 407 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.61% |
1 day | +5.88% | ||
1 week | +4.65% | ||
Current month | +12.50% | ||
1 month | +23.29% | ||
3 months | -7.22% | ||
6 months | +73.08% | ||
Current year | +25.00% |
Managers | Title | Age | Since |
---|---|---|---|
Zhi Gang Zhao
CEO | Chief Executive Officer | 64 | 01/14/01 |
Wei Tian
ADM | Chief Administrative Officer | 41 | - |
Jing Li
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Zhi Gang Zhao
CEO | Chief Executive Officer | 64 | 01/14/01 |
Da Wei Chen
BRD | Director/Board Member | 54 | 13/17/13 |
Kingsley Leung
CHM | Chairman | 37 | 08/13/08 |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 0.09 | +5.88% | 20 000 |
02/24/02 | 0.085 | +2.41% | 1,100,000 |
30/24/30 | 0.083 | -5.68% | 1,540,000 |
29/24/29 | 0.088 | +3.53% | 5,660,000 |
26/24/26 | 0.085 | +7.59% | 1,700,000 |
Delayed Quote Hong Kong S.E., May 03, 2024 at 07:00 am IST
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+25.00% | 65.39M | |
-3.54% | 86.16B | |
+2.76% | 40.17B | |
-17.49% | 31.47B | |
+54.44% | 25.24B | |
-13.13% | 15.82B | |
-9.12% | 11.96B | |
-15.45% | 11.89B | |
-42.56% | 11.61B | |
+4.87% | 8.84B |
- Stock Market
- Equities
- 690 Stock